What Are the Challenges in Treating Fungal Infections in Cancer Patients?
Treating fungal infections in cancer patients involves several challenges. One significant issue is drug resistance, which can limit the effectiveness of conventional treatments. Additionally, the potential for drug interactions is a concern, as cancer patients often take multiple medications, increasing the risk of adverse effects. The toxicity of certain antifungal drugs, such as amphotericin B, can also pose a barrier to treatment, especially in patients already weakened by cancer therapies.
